Formidable Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,057
Closed -$14.1K 377
2024
Q2
$14.1K Sell
1,057
-50
-5% -$1.49K ﹤0.01% 391
2024
Q1
$51.4K Buy
1,107
+20
+2% +$1.03K 0.01% 383
2023
Q4
$73.5K Buy
1,087
+487
+81% +$29.8K 0.02% 277
2023
Q3
$43.4K Buy
600
+55
+10% +$4.4K 0.01% 280
2023
Q2
$41K Buy
545
+29
+6% +$1.72K 0.01% 280
2023
Q1
$27K Buy
516
+7
+1% +$444 0.01% 301
2022
Q4
$34K Hold
509
0.01% 306
2022
Q3
$56K Buy
509
+1
+0.2% +$119 0.01% 288
2022
Q2
$64K Buy
508
+123
+32% +$15K 0.01% 295
2022
Q1
$62K Buy
+385
New +$74.9K 0.01% 330
2021
Q4
Sell
-1,507
Closed -$699K 327
2021
Q3
$699K Buy
+1,507
New +$734K 0.13% 151

Other funds holding DNA